Inhibition of 14‐3‐3 proteins increases the intrinsic excitability of mouse hippocampal CA1 pyramidal neurons

Abstract

Abstract14‐3‐3 proteins are a family of regulatory proteins that are abundantly expressed in the brain and enriched at the synapse. Dysfunctions of these proteins have been linked to neurodevelopmental and neuropsychiatric disorders. Our group has previously shown that functional inhibition of these proteins by a peptide inhibitor, difopein, in the mouse brain causes behavioural alterations and synaptic plasticity impairment in the hippocampus. Recently, we found an increased cFOS expression in difopein‐expressing dorsal CA1 pyramidal neurons, indicating enhanced neuronal activity by 14‐3‐3 inhibition in these cells. In this study, we used slice electrophysiology to determine the effects of 14‐3‐3 inhibition on the intrinsic excitability of CA1 pyramidal neurons from a transgenic 14‐3‐3 functional knockout (FKO) mouse line. Our data demonstrate an increase in intrinsic excitability associated with 14‐3‐3 inhibition, as well as reveal action potential firing pattern shifts after novelty‐induced hyperlocomotion in the 14‐3‐3 FKO mice. These results provide novel information on the role 14‐3‐3 proteins play in regulating intrinsic and activity‐dependent neuronal excitability in the hippocampus.